4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-21-022682
Chief Executive Officer sold 30,000 shares at an average $35.59 ($1,067,611)
From the SEC's structured data for this filing
Trades in this filing
Lynch Casey · Chief Executive Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-22 | Sale : show line 1 in the form | −11,211 | $35.10 | $393,506 | 1,027,563 | I |
| 2021-03-22 | Sale : show line 2 in the form | −18,089 | $35.85 | $648,491 | 1,009,474 | I |
| 2021-03-22 | Sale : show line 3 in the form | −300 | $36.58 | $10,974 | 1,009,174 | I |
| 2021-03-22 | Sale : show line 4 in the form | −400 | $36.60 | $14,640 | 1,008,774 | I |
| Open-market sales · 30,000 sh · avg $35.59 · $1,067,611 | ||||||
Loading xslF345X03/doc4.xml…